The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
Pharmena S.A.
+ business areaBioPharma R&D+Services
+ annual revenue
2021 – 16,131,000 PLN
2022 – 20,051,000 PLN
2023 – 1,251,000 PLN
2024 – 268,000 PLN
+ workforce (estimated if not reported)
2024 - 7
Pharmena S.A., a publicly listed Polish biotechnology company, develops and commercializes innovative products based on its patented natural active compound 1-MNA. Its work spans clinical research on anti-inflammatory and anti-fibrotic therapies, as well as the introduction of medical devices and dietary supplements addressing specific nutritional needs.